Publications by authors named "D M Jeevan"

Disease recurrence following chemotherapy is a major clinical challenge in ovarian cancer (OC), but little is known regarding how the tumour epigenome regulates transcriptional programs underpinning chemoresistance. We determine the single cell chromatin accessibility landscape of omental OC metastasis from treatment-naïve and neoadjuvant chemotherapy-treated patients and define the chromatin accessibility profiles of epithelial, fibroblast, myeloid and lymphoid cells. Epithelial tumour cells display open chromatin regions enriched with motifs for the oncogenic transcription factors MEIS and PBX.

View Article and Find Full Text PDF

Human epididymis 4 (HE4) is a promising ovarian cancer biomarker, but it has not been evaluated in primary care. In this prospective observational study, we investigated the diagnostic accuracy of HE4 alone and in combination with CA125 for the detection of ovarian cancer in symptomatic women attending primary care. General practitioner (GP)-requested CA125 samples were tested for HE4 at a large teaching hospital in Manchester, and cancer outcomes were tracked for 12 months.

View Article and Find Full Text PDF

Background: The pattern of cranial venous drainage in syndromic craniosynostosis is unpredictable and not adequately understood. Collateral channels substitute for stenotic venous sinuses and pose potential risk for surgical intervention. The purpose of this study was to analyze the patterns of venous drainage in patients with syndromic craniosynostosis and their influence on operative planning and morbidity.

View Article and Find Full Text PDF

Ruptured intracranial aneurysms are extremely rare in infants. The optimal treatment strategy is not well established. Both microsurgical and endovascular techniques and strategies have been tried, and in the literature there is a significant variability in outcome.

View Article and Find Full Text PDF
Article Synopsis
  • Brain metastases from cancer are a major cause of illness and death, stemming from the ability of tumor cells to spread from the primary site through processes like epithelial-to-mesenchymal transition (EMT) and mesenchymal-to-epithelial transition (MET).
  • Researchers used various analysis techniques, including immunohistochemistry and gene expression studies, to assess markers of EMT, MET, and stemness in brain tumor samples.
  • Findings revealed that metastatic brain tumors showed co-expression of epithelial and mesenchymal markers, indicating a transitional state, along with high levels of stem cell markers, suggesting an intricate relationship between these processes in cancer metastasis.
View Article and Find Full Text PDF